Case Report: Erythema gyratum repens associated with adenomyosis and endometriosis: an immunological twist? - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Case Study of Erythema Gyratum Repens Linked to Adenomyosis and Endometriosis: An Immunological Perspective?

  • By

  • Emanuele Scala

  • Donatella Sordi

  • Arlind Kalaja

  • Francesca Passarelli

  • Lidia Francesconi

  • Filomena Russo

  • July 10, 2026

Share

  • 1

    A 37-year-old woman presented with pruritic erythematous plaques suggestive of erythema gyratum repens (EGR) and had a history of pelvic pain and menorrhagia.

  • 2

    Routine lab tests showed an elevated CA-125 level, while other tumor markers and autoantibody panels were unremarkable.

  • 3

    A targeted gynecological assessment revealed severe adenomyosis and concomitant endometriosis, leading to a total hysterectomy.

  • 4

    The patient's cutaneous eruption resolved completely within 2 months post-surgery without further dermatologic intervention.

  • 5

    This case highlights the potential for non-paraneoplastic conditions, such as chronic inflammatory gynecological diseases, to be associated with EGR.

Original Source(s)

Case Report: Erythema gyratum repens associated with adenomyosis and endometriosis: an immunological twist?

  • by Emanuele Scala, Donatella Sordi, Arlind Kalaja, Francesca Passarelli, Lidia Francesconi, Filomena Russo

  • July 10, 2026

Related Content

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

Anatomical site and histological subtype as determinants of Breslow thickness and high-risk features in surgically managed cutaneous melanoma at Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa

What shapes patient attitudes toward TBP skin cancer screening?

Expert consensus highlights communication, privacy, and staff interactions as priorities for a proposed patient-reported experience measure.